The specific nitrogen flame-ionization detector was used for the rapid simultaneous determination of eight anticonvulsant drugs and one drug metabolite in plasma and for three of the drugs in tissues. The system of analysis allows the occasional rapid estimation of barbiturate in plasma. No derivative formation is required and the whole range of drugs can be determined in a single diethyl ether extract of plasma in about 20 mm.
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The principal contribution of gas-liquid chromatography to clinical chemistry has been in the areas of steroid biochemistry and clinical toxicology. As most drugs contain at least one nitrogen atom, it appeared likely that a detector that has increased sensitivity and selectivity for organic nitrogen would bring improvements to established toxicological procedures. For example, the rapid analysis for basic drugs in urine by Donike et al. (1, 2) at the 20th Olympic Games first demonstrated in practical terms how the rapid and specific determination of stimulant drugs can be improved by use of the nitrogen detector.
In the clinical laboratory, one of the fastest growing areas is the monitoring of anticonvulsant concentrations in the blood of epileptic patients. In our laboratory the number of such plasma samples for analysis has increased from 378 in 1970 to 1713 in 1973, most of them from other hospitals.
This assay, as a routine determination, done on a dedicated gas chromatograph with the nitrogen-selective detector, has been in use at least 5 days a week, for longer than 18 months. To analyze as many anticonvulsant drugs as possible on one particular column system and to provide a service for occasional barbiturate analyses, we now use the selective nitrogen flame detector. This modified detector is so specific and sensitive that we need only small plasma sample volumes (e.g., 0.2 ml). Table 1 shows some anticonvulsant drugs that can be determined in a single plasma extract, although not all of them can be assayed simultaneously. For example, ethotoin and pheneturide cannot be determined in the same sample, a compound assumed to be an ethotoin metabolite is not completely separated from carbamazepine, and mesantoin elutes in the same position as one of the internal standards. In practice, however, these problems are of minor importance. No patient has yet been studied who is receiving both pheneturide and ethotoin. Where mesantoin has been analyzed, it has been possible to select another drug for use as internal standard in place of heptabarbital; cyclobarbital is the standard of choice in this case.
Phenytoin was firstchromatographed with the aid of the nitrogen detector by Riedmann (3), using on- 
Materials and Methods

Reagents
Diet hyl ether. Analytical reagent-grade solvent was distilled over copper gauze and stored under nitrogen.
Ammonium sulfate. Analytical reagent-grade solid was washed with the purified ether.
Internal Standards
Heptabarbital, obtained as the free acid from Ciba-Geigy, was dissolved in methanol (2 mg/ml).
Methyl phenyl phenyihydantoin
was obtained from the Aldrich Chemical Co. Milwaukee, Wis. 53233.
Phenyl ethyl malondiamide
was a generous gift from Dr. H. Schafer, Desitin-Werke, Hamburg, West Germany.
Standards
The pure drugs were dissolved in methanol
(1 mg/ ml) and 2-ml aliquots stored at 4 #{176}C.
Standard curves were prepared by adding 5, 10, 25, and 50 tag, respectively, to 1-ml samples of drug-free pooled plasma. The plasma was extracted and chromatographed in the manner described below, to ascertain if there are any interfering peaks. The internal standards were added to the standard plasma samples and also to the unknown samples in amounts equivalent to 20 ag of heptabarbital and 10 zg of methyl phenyl phenyihydantoin per milliliter of plasma. These particular concentrations were chosen because the methyl phenyl phenylhydantoin is used as the internal standard for the drugs primidone and phenytoin, whereas heptabarbital is used as the internal standard for all the other drugs except mesantom.
Extraction
Plasma. Plasma, 0.2 ml, containing, respectively, 4 and 2 g of heptabarbital and methyl phenyl phenylhydantoin, was extracted with 5 ml of diethyl ether by shaking for 2 mm. Sufficient solid ammonium sulfate (about 200 mg) was added to the mixture to saturate the aqueous layer and the shaking was repeated. It is important that the drugs are extracted into the ether before the ammonium sulfate is added, because the resulting plasma protein precipitation may result in the co-precipitation of some of the more strongly bound compounds. The addition of ammonium sulfate makes it unnecessary to dry the separated ether phase.
The ether layer was poured directly into a glass centrifuge tube and evaporated in a water bath at 50 #{176}C. The residue was reconstituted in 25 tl of methanol, then 1 to 2 tl of this solution was injected into the gas chromatograph.
The 0.2-ml plasma sample is a convenient size for use in this type of analysis; however, the assay is sufficiently sensitive to permit use of as little as 50 zl of plasma.
Tissues. Tissue samples (0.2-1 g) were mixed with the two internal standards in the proportion of 20 zg of heptabarbital and 10 g of methyl phenyl phenylhydantoin to 1 g of solid sample, and the whole mixture was sonicated for 30 s in 10 ml of ethanol. The solution was filtered through Whatman
No. 1 filter paper, then evaporated in a rotary evaporator at 40 #{176}C, the residue dissolved in 10 ml of chloroform, and the extraction continued as described previously (7).
Gas Chromatography
The Series 5750 Gas Chromatography (Hewlett- Figure 1 shows the seven compounds plus two internal standards that are determined in a plasma extract. The most common determination, shown in Figure 2 , is of the four compounds, phenyl ethyl malondiamide, phenobarbital, primidone, and phenytoin. 8. phenytoin; and 9, methyl phenyl phenylhydantoin (internal standard).
Fig. 1. Chromatogram of an ether extract of plasma
The three small peaks marked with an asterisk are unknown endogenous plasma peaks.
The chromatogram shows the analysis of a plasma sample from a patient who was receiving phenobarbital, primidone. and phenytoin. The drugs ethotom and ethosuxlmide were added to he plasma before it was extracted. Peak 4 has a retention time of 16 mm. The column is programmed from 150 #{176}C for 2 mm, then at 15 #{176}C/min to 265 #{176}C for 8 mm Gas-chromatographic selectivity.
The nitrogen flame-ionization detector responds proportionally to the percent nitrogen content of the organic compound, independent of its chemical structure (9). The combined characteristics of selectivity, sensitivity, with the linear range of the normal flame ionization detector make the nitrogen detector the detector of choice for analysis of organic nitrogen-containing compounds.
For this combination of selectivity and sensitivity, the rubidium bromide crystal must be carefully "tuned" with respect to the detector flame. The common practice is to use a combination hydrocarbon and azobenzene injection, as proposed by the instrument manufacturer, but Donike and Stratmann (2) showed that use of a drug or drugs involved in the analysis is more convenient.
Thus we adopt the procedure that involves the use of an ether extract of plasma along with heptabarbital, as illustrated in Figure 3 . Chromatograms illustrating how the detector may be "tuned"
The peak marked H is heptabarbital, and C is the cholesterol peak.
The approximate point of maximum sensitivity and selectivity of the nitrogen detector is determined by the injection of a 50-ng sample of heptabarbital. This is followed by the plasma extract (left) containing 50 ng of heptabarbital and about 2.5 pg of cholesterol. The rubidium bromide crystal is moved vertically so that the cholesterol peak is first diminished (center) then eliminated (right). The solvent peak Is also minimized by the same process.
This procedure should be checked at least once a week.
Analytical Variables
Carbamazepine
and ethotoin. Figure 4 shows the problem that occurs when these two compounds are analyzed together.
Although ethotoin can be determined in the normal way, a peak always appears on the side of the carbamazepine peak, which is presumed to be an ethotoin metabolite, as it is found only in plasma samples from patients receiving ethotom. Back extraction into sodium hydroxide solution, as reported previously (7), eliminates this interfering peak.
Barbiturate drugs. The common barbiturates, butobarbital, amylobarbital, pentobarbital, and quinalbarbital, along with barbital, can be adequately resolved on this column. Figure 5 shows the technique used to identify a barbiturate.
In Figure 5 (left-hand chromatogram) the sample is chromatographed alone to detect the presence of a suspected barbiturate drug. A standard of known composition is chromatographed, followed by the two mixed together. As Figure 6 illustrates, these barbiturate drugs chromatograph in the same region as pheneturide and ethotom; thus further confirmation of the barbiturate structure should be sought in the direct ether extract.
If the extract of plasma is back-extracted into sodium hydroxide solution (7), neither pheneturide nor ethotom is extracted into the sodium hydroxide solution, whereas all the barbiturates are. The current method does not separate these two compounds; however, the identification of an unknown peak with a retention time of ethotoin or pheneturide is aided by the presence of a possible ethotoin metabolite on the side of the carbamazepine peak. We made several unsuccessful attempts to improve the sensitivity for carbamazepine. This particular compound undergoes acid-catalyzed degradation and decomposition when chromatographed on polar columns (10), and the phases WG-11 and SP-1000 are no exception.
In spite of the reported lack of degradation of the compound on injection with ethanol as compared to methanol (10), in a comparative study involving a series of six independent determinations with each solvent, we found no significant difference.
Precision and accuracy.
The precision of the assay was determined by analyzing independently 10 samples of horse serum containing 1 mg of the drugs per milliliter (except phenobarbital, of which 2 mg/100 ml was added). The coefficients of variation for each drug are given in 
Information of Clinical Interest
Therapeutic ranges.
The therapeutic concentrations of several of these drugs have already been reported (11). However, further analyses now enable us to re-assess some of these ranges (Table 1) . Here, the term "therapeutic" is defined as that concentration at which no toxic symptoms were reported by the clinician on his request form for that particular analysis. Although such a system is obviously open to various criticisms, particularly in view of the sparse clinical details often given, it is the only one available to clinical chemists. A zero value for carbamazepine is included, because we have investigated several cases in which the clinician is assured that the patient is taking the drug and yet none can actually be determined in the plasma. However, in two such patients the drug was detected in the urine, and we concluded that their plasma concentrations were below the sensitivity of the assay. This particular phenomenon appears to occur only with adults; the drug can always be detected in children, where there is good evidence that the patient is actually taking the drug.
Concentrations in tissues.
Figure 7 shows results of a determination of the three drugs, phenobarbital, primidone, and phenytoin. The current method of extraction of the drugs, particularly from brain, is designed for these three compounds.
Of the other 2i drugs, ethosuximide would appear in the same fraction, but we examined no tissue samples containing this substance.
We conclude that the system clearly demonstrates that rapid routine gas-chromatographic analysis of anticonvulsant drugs can be made on a plasma sampie taken on an out-patient basis, while that particu-lar patient is being seen in the out-patient department. This service is available because of the nitrogen detector. The latter is somewhat more demanding of the operator than the normal flame-ionization detector is, but it does not have the problems inherent in the easily contaminated electron-capture detector. The nitrogen detector has a great deal to offer routine clinical chemistry.
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